Oxybutynin News

← Back to News Overview

---

Oxybutynin currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Oxybutynin with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Original indication: Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder.
• Evidence level: L5
• Predicted indications (20):
  • cauda equina syndrome (99.9%)
  • overactive bladder (disease) (99.8%)
  • restless legs syndrome (99.7%)
  • obsolete neurogenic bladder (disease) (99.7%)
  • gastroduodenitis (99.6%)
  • peptic ulcer disease (99.3%)
  • low compliance bladder (97.9%)
  • nephrogenic syndrome of inappropriate antidiuresis (97.5%)
  • insomnia (disease) (96.9%)
  • attention deficit-hyperactivity disorder (95.1%)
  • faciodigitogenital syndrome (95.0%)
  • familial episodic pain syndrome with predominantly upper body involvement (92.6%)
  • transient tic disorder (92.5%)
  • migraine disorder (92.1%)
  • migraine with brainstem aura (92.0%)
  • sleep disorder, initiating and maintaining sleep (91.8%)
  • bladder neck obstruction (91.3%)
  • communication disorder (90.7%)
  • stereotypic movement disorder (90.6%)
  • fetal nicotine spectrum disorder (90.6%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.